WESSEX PHARMACEUTICALS LIMITED, Clindamycin Import Data from India (DGFT 2022–2026)

Q: Who are the top buyers of Clindamycin from India and how much does WESSEX PHARMACEUTICALS LIMITED, import?

India exports Clindamycin to 1,029 buyers globally worth $31.6M. WESSEX PHARMACEUTICALS LIMITED, imports $311.0K (0.7% market share) with 13 shipments from KENYA.

Q: What is the average order value for WESSEX PHARMACEUTICALS LIMITED,'s Clindamycin imports?

WESSEX PHARMACEUTICALS LIMITED,'s average Clindamycin order value is $23.9K per consignment, based on 13 shipments totaling $311.0K.

Q: Who supplies Clindamycin to WESSEX PHARMACEUTICALS LIMITED,?

WESSEX PHARMACEUTICALS LIMITED, sources Clindamycin from 1 verified supplier: ATOZ PHARMACEUTICALS PRIVATE LIMITED ($311.0K, 100.0%). Based on 13 customs records.

Q: How does WESSEX PHARMACEUTICALS LIMITED, compare to other Clindamycin importers?

WESSEX PHARMACEUTICALS LIMITED, ranks #19 among 1,029 Clindamycin importers from India with 0.7% market share and 13 shipments.

Q: Who are the top Clindamycin importers from India?

Top Clindamycin importers: CARDINAL HEALTH ($4.7M), AIM RX 3PL, LLC ($3.3M), EVERSANA LIFE SCIENCE SERVICES ($3.1M), IPD, SC, USA ($3.0M), NORTHSTAR DISTRIBUTION CENTER 8912 ($2.9M).

Suresh Sormare

Clindamycin

India Pharmaceutical Trade Intelligence

$90.2M527 Suppliers144 CountriesHS 30042095

ExportsIndia → UNITED STATES60.9%India → KENYA5.1%

ImportsBELGIUM → India$14.3B FRANCE → India$32.3M

#1 Supplier: ENCUBE ETHICALS #1 Buyer: CARDINAL HEALTH

WESSEX PHARMACEUTICALS LIMITED, — Clindamycin Importer #19 | $311.0K Trade Value | TransData Nexus | TransData Nexus

WESSEX PHARMACEUTICALS LIMITED, — Clindamycin Importer Profile

Pharmaceutical Importer · #19 buyer for Clindamycin · $311.0K import value · 13 shipments · KENYA · DGFT Verified

WESSEX PHARMACEUTICALS LIMITED, is the #19 importer of Clindamycin from India with $311.0K in import value and 13 verified shipments. WESSEX PHARMACEUTICALS LIMITED, holds a 0.7% market share in Clindamycin imports based in KENYA. The company sources from 1 verified supplier across 7 formulations shipped to 1 country.

WESSEX PHARMACEUTICALS LIMITED, — Clindamycin Import Profile: Suppliers, Formulations & Sources

WESSEX PHARMACEUTICALS LIMITED, — Clindamycin import analysis from Indian Customs (DGFT) data.

Who Actually Supplies Clindamycin to WESSEX PHARMACEUTICALS LIMITED,?

Verified from 13 customs shipment records

Supplier	Value	Shipments	% Share
ATOZ PHARMACEUTICALS PRIVATE LIMITED	$311.0K	13	100.0%

WESSEX PHARMACEUTICALS LIMITED, sources Clindamycin from 1 verified Indian supplier based on 13 customs records. The primary supplier is ATOZ PHARMACEUTICALS PRIVATE LIMITED accounting for 100.0% of imports.

How Does WESSEX PHARMACEUTICALS LIMITED, Compare to Nearest Clindamycin Importers?

Buyers ranked immediately above and below #19 by import value

#	Buyer	Country

Where Does WESSEX PHARMACEUTICALS LIMITED, Import Clindamycin To?

Destination countries from 13 verified shipments

Country	Value	Shipments	Share
KENYA	$311.0K	13	100.0%

WESSEX PHARMACEUTICALS LIMITED, imports Clindamycin to 1 country. The primary destination is KENYA receiving 100.0% of shipments worth $311.0K.

What Clindamycin Formulations Does WESSEX PHARMACEUTICALS LIMITED, Import?

Formulation	Value	Shipments
CLINDAMYCIN 300 MG TABLET B.NO.KE 14 202	$103.6K	3
CLINDAMYCIN 300 MG TABLET B.NO.KE 14 201	$102.7K	3
CLINDAMYCIN 150 MG CAPSULE B.NO.KE 13 20	$101.0K	3
CLINDAMYCIN 300 MG CAPSULE BATCH NO.KE14401 MFG DT : 05/2024 EXP DT : 04/2026 DACILLIN-300	$2.5K	1
CLINDAMYCIN 300 MG CAPSULE B.NO.KE 14	$623	1
DACILLIN 300 CLINDAMYCIN 300 MG TABLET B	$496	1
CLINDAMYCIN 150 MG CAPSULE B.NO.KE 13 30	$49	1

WESSEX PHARMACEUTICALS LIMITED, imports 7 distinct Clindamycin formulations from India. The top formulation is CLINDAMYCIN 300 MG TABLET B.NO.KE 14 202 with 3 shipments worth $103.6K.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Product Matching: Clindamycin shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature and HS code classification.
2.Buyer Identification: WESSEX PHARMACEUTICALS LIMITED, matched across shipments using first-3-word normalization of the consignee field, accounting for company name formatting variations.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort buyer rankings.
4.Market Share: Calculated as WESSEX PHARMACEUTICALS LIMITED,'s capped import value divided by total capped export value for Clindamycin across all Indian exporters.
5.Verified Records: This page is backed by 13 individual customs records matching WESSEX PHARMACEUTICALS LIMITED, importing Clindamycin, covering 7 formulations from 1 verified supplier.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

Global Coverage

Exports to 144+ countries, 1,029+ buyers

Expert-Reviewed

Analyzed by pharmaceutical trade specialists

6	AUROLOGISTICS LLC, (AUROBINDO PHARM	UNITED STATES	$1.1M	22	$50.0K
11	AUROLOGISTICS LLC	UNITED STATES	$800.0K	16	$50.0K
19	WESSEX PHARMACEUTICALS LIMITED, ★	KENYA	$650.0K	13	$50.0K
16	EVERSANA	UNITED STATES	$600.0K	12	$50.0K

Clindamycin

Clindamycin

WESSEX PHARMACEUTICALS LIMITED, — Clindamycin Importer Profile

WESSEX PHARMACEUTICALS LIMITED, — Clindamycin Import Profile: Suppliers, Formulations & Sources

Who Actually Supplies Clindamycin to WESSEX PHARMACEUTICALS LIMITED,?

How Does WESSEX PHARMACEUTICALS LIMITED, Compare to Nearest Clindamycin Importers?

Where Does WESSEX PHARMACEUTICALS LIMITED, Import Clindamycin To?

What Clindamycin Formulations Does WESSEX PHARMACEUTICALS LIMITED, Import?

Who Are the Top Buyers of Clindamycin from India and How Much Does WESSEX PHARMACEUTICALS LIMITED, Import?

What Is the Average Order Value for WESSEX PHARMACEUTICALS LIMITED,'s Clindamycin Imports?

Who Supplies Clindamycin to WESSEX PHARMACEUTICALS LIMITED,?

How Does WESSEX PHARMACEUTICALS LIMITED, Compare to Other Clindamycin Importers?

Market Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Get Clindamycin Import Data for WESSEX PHARMACEUTICALS LIMITED,

WESSEX PHARMACEUTICALS LIMITED, × Clindamycin

Related Analysis

Need Detailed Import Data?

Data Source